Congress Abstracts 2003

For your convenience, all Podium and Poster Abstracts have been indexed according to number, subject and first author.

The abstracts appear exactly as they were submitted and have not undergone editing or the Oncology Nursing Forum Editorial Board’s review process. We have made every effort to be accurate. If any errors or omissions have been made, please accept our apologies.

Abstracts that are not being presented do not appear.

1
THE REVISED I CAN COPE—A MODEL OF COLLABORATION.

2
DEVELOPING A COMPREHENSIVE ART THERAPY PROGRAM.

3
A MULTIDISCIPLINARY APPROACH TO CREATING A BEREAVEMENT PROGRAM IN A TERTIARY HOSPITAL SETTING.

4
DELEtCC: DISSEMINATING END-OF-LIFE EDUCATION TO CANCER CENTERS.

5
DESIGNING OUTPATIENT FLOW: SAILING THROUGH THE STORM.

6
EFFECTIVE STRATEGIES FOR DECREASING UNSCHEDULED WALK-IN INFUSION APPOINTMENTS.

7
LINICAL INSIGHTS SHARED BY NURSE CANCER SURVIVORS.

8
COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN THE PROSTATE CANCER POPULATION: THE ROLE OF THE AMBULATORY NURSE.

9
TRANSCENDING BREAST CANCER.

10
ENHANCING ADAPTATION FOLLOWING RADIATION TREATMENT: CONCRETE INFORMATION VERSUS EMOTIONAL EXPRESSION.

11
IMPROVING CANCER PAIN MANAGEMENT FOR HOMECARE NURSES.

12
SAFEGUARDING AN ENDANGERED SPECIES: SUSTAINING THE HEART, MIND, AND SPIRIT OF THE ONCOLOGY CAREGIVER.

13
BEYOND ORIENTATION: SUPPORTING THE NEW AND EXPERIENCED ONCOLOGY NURSE.

14
DEVELOPING AND IMPLEMENTING A CONSULTATIVE SERVICE FOR NURSES PURSUING OCN^® CERTIFICATION.

15
MONITORING, MEASURING, AND MANAGING CANCER NURSING RESOURCES: RESULTS OF ONE INSTITUTION’S “REPORT CARD” EFFORTS.

16
THE TREATMENT OF ADVANCED PROSTATE CANCER WITH KETOCONAZOLE.

17
ADVANCING ONCOLOGY NURSING PRACTICE: MONTHLY COLLABORATIVE CASE STUDY PRESENTATIONS.

18
MULTIDISCIPLINARY MANAGEMENT OF CANCER-RELATED MALNUTRITION IN AN INPATIENT GASTROINTESTINAL/HEPATOBILIARY UNIT.

19
MANAGING PATIENT POST HEPATIC ARTERIAL EMBOLIZATION: THE INPATIENT NURSE’S ROLE.

20
END-OF-LIFE EDUCATION FOR CONTINUING EDUCATION PROVIDERS.

21
TOTAL SYMPTOM SCORES IMPACT HOSPICE PATIENTS’ FUNCTIONAL STATUS AND QUALITY OF LIFE.

22
GRIEF AND LOSS FOR PROFESSIONALS: PROVIDING A SHELTERING FORUM FOR EXPRESSION, FEEDBACK, AND VALIDATION THROUGH “STAFF GRIEF AND LOSS ROUNDS.”

23
TESTING OUTCOMES OF PALLIATIVE CARE AND SYMPTOM MANAGEMENT TRAINING FOR PARAPROFESSIONALS (NURSING ASSISTANTS AND HOME HEALTHCARE AIDES) IN THE NURSING HOME AND REHABILITATION SETTING.

24
IMPROVING CHEMOTHERAPY SAFETY IN A MULTISPECIALTY TERTIARY REFERRAL CENTER.

25
DON’T WAIT FOR SOMETHING BAD TO HAPPEN TO CHANGE PRACTICE: AVOIDANCE OF SENTINEL EVENTS BY LEARNING FROM NEAR MISSES.

26
HANDS-ON LEARNING: EDUCATING NEW ONCOLOGY NURSES IN A SKILLS LAB ENVIRONMENT.

27
THE CHEMO OLYMPICS: A FUN APPROACH TO SAFETY IN CHEMOTHERAPY PRACTICE.

28
PERCEIVED CANCER WORRY IN WOMEN WITH HEREDITARY RISK FACTORS FOR BREAST CANCER.

29
CANCER FAMILY HISTORY: HOW TO DRAW A PEDIGREE.

30
ADVOCATING FOR FUTURE GENERATIONS: SPERM BANKING.

31
DEVELOPING NICARAGUAN NURSES AS LEADERS IN CANCER PREVENTION AND CONTROL: PREPARATION FOR A NURSE-MANAGED, COMMUNITY-BASED BREAST AND CERVICAL CANCER PREVENTION AND CONTROL PROGRAM.

32
PERFORMANCE IMPROVEMENT: STRATEGIES FOR SUCCESS.

33
CULTIVATING SYMPTOM MANAGEMENT EXPERTISE ON AN INPATIENT ONCOLOGY UNIT.

34
STRATEGIES FOR THE SUCCESSFUL INTEGRATION OF AGENCY NURSES: MEETING THE CHALLENGES OF A NURSING SHORTAGE.

35
EVIDENCE-BASED PRACTICE: A METHOD OF IMPROVING NURSING PRACTICE.

36
MEASURING NAUSEA, VOMITING, AND RETCHING: THE MODIFIED RHODES INDEX OF NAUSEA AND VOMITING SHORT VERSION FOR RESEARCH AND CLINICAL USE.

37
SYMPTOM TRAJECTORY FOLLOWING 12 WEEKS OF BIOTHERAPY.

38
EVALUATING THE RELATIONSHIP BETWEEN CANCER PAIN INTENSITY, SATISFACTION WITH PAIN RELIEF, AND ATTITUDINAL BARRIERS TO PAIN MANAGEMENT: ANOTHER LOOK.

39
THE EXPERIENCE OF CHEMOTHERAPY-INDUCED NEUTROPENIA: QUALITY-OF-LIFE INTERVIEWS WITH ADULT CANCER PATIENTS.

40
ENGRAFTMENT SYNDROME POST NONMYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: NURSING’S ROLE IN EARLY DETECTION AND TREATMENT.

41
HEALTH PROMOTION AND BACK TO BASICS: INFLUENZA VACCINATION IN AN ADULT ONCOLOGY POPULATION.

42
THE DEVELOPMENT OF A COMMUNITY ONCOLOGY COST MODEL FOR CHEMOTHERAPY-INDUCED NEUTROPENIA.

43
A PROSPECTIVE EVALUATION OF PALLIATIVE OUTCOMES OF SURGERY FOR ADVANCED MALIGNANCIES.

44
RESPIRATORY SYMPTOMS AND PULMONARY STATUS OF SURVIVORS OF NON-SMALL CELL LUNG CANCER.

45
A PROSPECTIVE STUDY OF PATIENT SENSATIONS AFTER BREAST CANCER SURGERY: A TWO-YEAR FOLLOW-UP.

46
EVIDENCE-BASED PRACTICE GUIDELINES FOR PROACTIVE MANAGEMENT OF NEUTROPENIA.

47
IMPROVING PAIN MANAGEMENT FOR THE POSTOPERATIVE THORACIC SURGERY ONCOLOGY PATIENT UTILIZING EPIDURAL INFUSIONS.

48
THE NURSING ROLE IN THE MANAGEMENT OF STEREOTACTIC RADIOSURGERY FOR BRAIN TUMORS.

49
A NOVEL APPROACH TO TREATING PATIENTS AFTER RESECTION OF MALIGNANT BRAIN TUMORS: DEVELOPMENT OF A NURSING CARE PLAN.

50
PROVIDING INFORMATION FOR PATIENT RECOVERY: CREATION OF AN EDUCATION BOOKLET FOR BLADDER CANCER PATIENTS FOLLOWING CYSTECTOMY WITH NEOBLADDER RECONSTRUCTION.

51
A PHASE I/II STUDY TO EVALUATE THE OPTIMUM DOSE OF PEGYLATED-INTERFERON IN PATIENTS WITH PLATINUM-RESISTANT OVARIAN, PERITONEAL, OR FALLOPIAN TUBE CANCER: A NEW TREATMENT APPROACH FOR PATIENTS WITH RECURRENT DISEASE.

52
WHAT’S OLD IS NEW AGAIN: PATIENTS RECEIVING HEPATIC INTRA-ARTERIAL CHEMOTHERAPY.

53
TREATMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA WITH HIGH-DOSE METHOTREXATE: NURSING’S UNIQUE CONTRIBUTION.

54
ARSENIC TRIOXIDE: NURSING CONSIDERATIONS FOR SAFE ADMINISTRATION.

55
LYMPHEDEMA FOLLOWING BREAST CANCER TREATMENT, INCLUDING SENTINEL LYMPH NODE BIOPSY.

56
NURSING BEHAVIORAL INTERVENTION TRIAL RESULTS IN FEWER HOSPITALIZATIONS AMONG CANCER PATIENTS UNDERGOING CHEMOTHERAPY.

57
OUTCOMES OF COMPLEMENTARY THERAPY USE BY CHEMOTHERAPY PATIENTS.

58
SLEEP, FATIGUE, AND DEPRESSIVE SYMPTOMS IN BREAST CANCER SURVIVORS AND MATCHED HEALTHY WOMEN EXPERIENCING HOT FLASHES.

59
EMPLOYEE MAMMOGRAPHY INREACH PROGRAM AS A MODEL FOR EFFECTIVE BREAST CANCER SCREENING.

60
WALKER COUNTY, AL, CANCER SCREENING PROJECT.

61
MEDICATION ERROR PREVENTION IN THE OFFICE SETTING.

62
A RECOGNIZED NEED: BLADDER CANCER SUPPORT GROUP AND THE ROLE OF THE AMBULATORY NURSE.

63
AN EVALUATION OF A STRUCTURED CHEMOTHERAPY TEACHING PROGRAM IN AN AMBULATORY SETTING.

64
USE OF THE TELEPHONE FOR DELIVERY OF NURSING INTERVENTIONS.

65
HOME HEALTH VERSUS TELENURSING OUTPATIENT MANAGEMENT OF ONCOLOGY PATIENTS WITH NEW OSTOMIES.

66
THE ADMINISTRATIVE CHALLENGE IN THE DEVELOPMENT OF A POINT-OF-SERVICE CLINIC FOR POST BLOOD AND MARROW TRANSPLANTATION PATIENTS.

67
ADVANCED CANCERS OF THE ORAL CAVITY: THE ROLE OF THE AMBULATORY CARE NURSE.

68
IMPROVING THE USE OF ANTIEMETICS FOR PROPHYLAXIS OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN AN OUTPATIENT CANCER CENTER.

69
A SYSTEM FOR THE SAFE ADMINISTRATION OF ORAL CHEMOTHERAPEUTIC AGENTS IN THE HOME SETTING.

70
OUTPATIENT DOCUMENTATION FORMS FOR CHEMOTHERAPY AND RADIATION: COMPLYING WITH ONCOLOGY NURSING SOCIETY GUIDELINES.

71
CARING FOR OUTPATIENTS RECEIVING RADIOLABELED PHARMACEUTICAL AGENTS: GUIDELINES AND EDUCATIONAL TOOLS.

72
A COMMUNITY-FOCUSED MODEL FOR INTEGRATING A COMMUNITY-BASED GENETIC PROGRAM WITH A COMMUNITY CLINICAL ONCOLOGY PROGRAM: A NURSING INITIATIVE FOR PROGRAM DEVELOPMENT AND CANCER INTERVENTION.

73
THE IMPACT OF MEDICAL VISITS ON PATIENTS WITH CANCER.

74
A UROLOGIC CANCER SECOND OPINION SERVICE: HELPING PATIENTS MAKE INFORMED TREATMENT DECISIONS.

75
MANAGING VANCOMYCIN-RESISTANT ENTEROCOCCI IN IMMUNO-SUPPRESSED BLOOD AND MARROW STEM CELL TRANSPLANTATION PATIENTS IN THE OUTPATIENT SETTING: ARE WE DOING ENOUGH?

76
EFFICIENT SYSTEM TO SCHEDULE CHEMOTHERAPY AND SUPPORT THERAPIES FOR ONCOLOGY NURSES.

77
NEUTROPENIA IN ONCOLOGY PATIENTS: STANDARDIZING AN EDUCATION-AL APPROACH AND MEASURING OUTCOMES.

78
“BUTT BUSTERS: KIDS AGAINST SMOKING”: A PROGRAM TO EDUCATE ELEMENTARY STUDENTS ABOUT THE DANGERS OF SMOKING.

79
A BREATH OF FRESH AIR: ONCOLOGY NURSES INCREASING THE COMMUNITY’S AWARENESS ABOUT LUNG CANCER.

80
DEVELOPMENT AND IMPLEMENTATION OF PATIENT AND FAMILY EDUCATION COORDINATOR ROLE FOR HOSPITALIZED ONCOLOGY PATIENTS.

81
THE HEPATIC ARTERIAL INFUSION THERAPY: THE INPATIENT NURSE’S ROLE IN PREVENTING COMPLICATIONS AND MAINTAINING PATIENT SAFETY THROUGH PATIENT EDUCATION.

82
A PATIENT EDUCATION VIDEO TO ENHANCE LEARNING OF ESSENTIAL INFORMATION IN THE IMMEDIATE POSTOPERATIVE PERIOD FOLLOWING SURGERY FOR BREAST CANCER.

83
NURSES AND PATIENTS: PARTNERS IN DEFINING EDUCATIONAL NEEDS.

84
OUTCOME EVALUATION OF A PATIENT EDUCATION NOTEBOOK FOR WOMEN WITH GYNECOLOGIC MALIGNANCY.

85
A PATIENT GUIDE TO CARE: COLLABORATION BY DEPARTMENT OF PATIENT PROVIDERS TO IMPROVE PATIENT EDUCATION.

86
SERVING MINORITIES: CREATING A COLLABORATIVE APPROACH TO MEET THE EDUCATIONAL NEEDS OF MULTICULTURAL INDIGENT GYNECOLOGIC CANCER PATIENTS.

87
PATIENT EDUCATION MATERIAL FOR CUTTING-EDGE CANCER TREATMENTS: NURSES IN INDUSTRY AND AT THE BEDSIDE COLLABORATING ON A CANCER VACCINE EDUCATIONAL TOOL.

88
GETTING MORE INFORMATION ABOUT THE PROBLEM: AN IMPORTANT COMPONENT FOR IMPROVEMENT OF PATIENT SATISFACTION.

89
AN INNOVATIVE APPROACH TO UTILIZING CANCER SURVIVORS IN TELEPHONE PEER SUPPORT PROGRAMS FOR BREAST CANCER AND PROSTATE CANCER PATIENTS.

90
NO ABSTRACT

91
GLEEVEC™ TREATMENT FOR CHRONIC MYELOID LEUKEMIA: THE NURSING MANAGEMENT CHALLENGE FROM CLINICAL TRIALS TO THE PRESENT.

92
HORMONAL MANIPULATIONS FOR PROSTATE CANCER: THE AMBULATORY NURSE PRACTITIONER’S ROLE.

93
THE ROLE OF THE ONCOLOGY NURSE IN IMPLEMENTING NEW TARGETED THERAPIES.

94
NURSING PRIMER ON CANCER VACCINES: WHAT YOU NEED TO KNOW TO EDUCATE YOUR PATIENTS.

95
GELCLAIR™: A NEW, PROMISING, COST-EFFECTIVE, ORAL AGENT FOR THE REDUCTION OF MUCOSITIS SEQUELAE.

96
PS 341: A NEW DRUG FOR THE TREATMENT OF RENAL CELL CARCINOMA: THE AMBULATORY NURSE’S ROLE.

97
A PHASE I/II STUDY OF XYOTAX™ (CT-2103), A TUMOR-TARGETED TAXANE, IN PATIENTS WITH RECURRENT OVARIAN CANCER.

98
“WHAT SHOULD I TELL MY CHILDREN?”: AN ONCOLOGY NURSING PERSPECTIVE

99
RELIEF FROM HOT FLASHES: DEFINING DISTRESS AND SATISFACTION.

100
CHEMOTHERAPY-INDUCED MENOPAUSAL SYMPTOMS IN WOMEN 21–45 YEARS OF AGE.

101
OPENING THE WINDOW ON HOT FLASHES.

102
PEGFILGRASTIM WAS OBSERVED TO BE AS SAFE AND EFFECTIVE AS FILGRASTIM IN ELDERLY PATIENTS WITH BREAST CANCER.

103
PROMOTING BREAST HEALTH AMONG YOUNG WOMEN IN COLLEGE THROUGH BREASTIVAL EVENTS.

104
”NO, IT’S NOT MASTITIS”: DIAGNOSIS OF AND INNOVATIVE COMBINATION TREATMENT FOR INFLAMMATORY BREAST CANCER.

105
EXPANDING THE COMFORT OF MASTECTOMY PATIENTS WITH THE PAPILLA GOWN.

106
FATIGUE, DEPRESSION, AND BIOMARKERS IN WOMEN WITH BREAST CANCER: A PILOT STUDY.

107
NO ABSTRACT

108
CONTEMPORARY MEASUREMENT OF SYMPTOM DISTRESS IN WOMEN WITH BREAST CANCER.

109
WEIGHT AND BODY COMPOSITION CHANGES IN PREMENOPAUSAL WOMEN RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST CANCER.

110
INFORMATION NEEDS OF WOMEN WITH BREAST CANCER IN RECOVERY.

111
VIRTUAL REALITY INTERVENTION FOR OLDER WOMEN WITH BREAST CANCER.

112
FACTORS RELATED TO DELAYED HEALTH-SEEKING BEHAVIOR IN PATIENTS WITH BREAST CANCER.

113
EVIDENCE-BASED PRACTICE: PSYCHOSOCIAL CARE FOR WOMEN NEWLY DIAGNOSED WITH BREAST CANCER.

114
A PILOT STUDY TO EXPLORE THE RESOURCES AND THE SELF-CARE ACTIVITIES OF WOMEN WITH SIDE EFFECTS FROM CONVENTIONAL BREAST CANCER THERAPY.

115
USING A SYMTOM DISTRESS TOOL IN AN OUTPATIENT BREAST CENTER.

116
SISTERS FOR BREAST HEALTH: IMPROVING THE HEALTH OF THE COMMUNITY.

117
RATIONALE FOR THE DEVELOPMENT OF THE FACT-N: A NEUTROPENIA-SPECIFIC QUALITY-OF-LIFE TOOL.

118
PATIENT-REPORTED DEPRESSION AND ANXIETY IN PATIENTS WITH CANCER IMPROVES FOLLOWING REDUCTION IN ANEMIA-RELATED FATIGUE WITH DARBEPOETIN ALFA THERAPY.

119
EFFECTS OF THE NEUTROPENIC DIET IN THE OUTPATIENT SETTING.

120
TARGETED COLONY-STIMULATING FACTOR USE IN PATIENTS AT RISK FOR NEUTROPENIC COMPLICATIONS FROM BREAST CANCER ADJUVANT CHEMOTHERAPY: CLINICAL IMPACT OF A PREDICTIVE RISK MODEL.

121
PEGFILGRASTIM (NEULASTA™) SUPPORTS DOSE-DENSE CHOP-R GIVEN EVERY 14 DAYS TO PATIENTS WITH NON-HODGKIN LYMPHOMA.

122
NEUTROPENIC PRECAUTIONS: A JOURNEY TO THE DEVELOPMENT OF EVIDENCE-BASED STANDARDS.

123
OPTIMIZED USE OF PHARMACOLOGIC AND COMPLEMENTARY THERAPIES TO DECREASE CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING.

124
EDUCATION FOR ONCOLOGY NURSING: APPLYING COMPLEMENTARY AND ALTERNATIVE MEDINCE IN THE PRACTICE SETTING.

125
AROMATHERAPY: GUIDELINES FOR SAFE INCORPORTATION INTO NURSING PRACTICE.

126
SUPPORTING THE SPIRITUAL CONNECTION: CREATION AND DEVELOPMENT OF A SPIRITUALITY QUEST GROUP FOR CANCER SURVIVORS.

127
LAUNCHING A COMPLEMENTARY THERAPY PROGRAM IN ONCOLOGY: A NURSING INITIATIVE IN HOLISTIC CARE.

128
CREATING AN ENVIRONMENT FOR CARING THROUGH STORYTELLING.

129
CANCER FITNESS: OUTCOME MEASURES AND FEATURES OF A THREE-TIERED PROGRAM.

130
COMPLEMENTARY AND ALTERNATIVE MEDICINE IN THE 21ST CENTURY IN THE UNITED STATES.

131
ROCKY MOUNTAIN TEAM SURVIVOR: A MODEL FOR A FITNESS AND ACTIVITY SUPPORT PROGRAM DESIGNED TO ENHANCE AND IMPROVE OVERALL QUALITY OF LIFE FOR WOMEN CANCER SURVIVORS.

132
DEVELOPING AND IMPLEMENTING A FAMILY-CENTERED CARE PROGRAM IN AN ACUTE CARE ONCOLOGY UNIT.

133
MEETING PATIENT NEEDS: INTEGRATING A HEALING ARTS PROGRAM TO CANCER CARE AND INTRODUCING THEM IN A UNIQUE AND MEANINGFUL WAY.

134
EFFECTS OF EXERCISE ON DAILY FATIGUE IN WOMEN WITH BREAST CANCER UNDERGOING CHEMOTHERAPY.

135
QUALITY OF LIFE AND FATIGUE IN LUNG CANCER PATIENTS: DOES A SEATED EXERCISE PROGRAM MAKE A DIFFERENCE?

136
SYMPTOM CLUSTERS PREDICT FATIGUE SEVERITY IN ONCOLOGY OUTPATIENTS.

137
INFLUENCE OF INTENSIVE CANCER PAIN MANAGEMENT IN THE DEVELOPMENT OF FATIGUE, HALLUCINATION, AND SEDATION.

138
WHO BENEFITS FROM ENERGY CONSERVATION FOR CANCER-RELATED FATIGUE?

139
FACTORS ASSOCIATED WITH FATIGUE IN WOMEN BEFORE AND AFTER SURGERY FOR BREAST CANCER.

140
FACTORS INFLUENCING FATIGUE DURING AND AFTER CHEMOTHERAPY: RESULTS OF A FEASIBILITY SLEEP INTERVENTION STUDY.

141
EVALUATING THE CLINICAL IMPORTANCE OF A FATIGUE ASSESSMENT TOOL: A PILOT STUDY.

142
WOMEN RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST CANCER: IMPACT ON QUALITY OF LIFE AND FATIGUE.

143
THE INFLUENCE OF CAREGIVER AGE AND GENDER, AND PATIENT CLINICAL FACTORS ON FAMILY CAREGIVERS’ PERCEPTIONS OF AND INVOLVEMENT IN CANCER PAIN MANAGEMENT.

144
NO ABSTRACT

145
A PILOT STUDY COMPARING PAIN INTENSITY, INFORMATION SEEKING, AND ADJUSTMENT TO PROSTATE CANCER AND METASTASIS IN FIRST-GENERATION JAPANESE AMERICAN MEN AND THIRD-GENERATION EUROPEAN AMERICAN MEN.

146
HISPANIC PERSPECTIVES ABOUT BELIEFS AND REMEDIES FOR ACUTE PAIN.

147
OPIOID PRESCRIPTION FOR CANCER PAIN MANAGEMENT.

148
CANCER-RELATED PAIN IN THE OUTPATIENT CLINIC.

149
WHEN IS RELIEF FROM CANCER PAIN POOR, FAIR, OR GOOD?

150
AN INSTITUTIONAL EXPERIENCE WITH THE IMPLEMENTATION OF JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS PAIN STANDARDS.

151
PAIN IN ADULT RECIPIENTS OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN KOREA.

152
GAINS ON PAIN.

153
LONG-TERM USE OF VENLAFAXINE FOR HOT FLASHES.

154
KNOWLEDGE IS POWER: ASSESSMENT TOOLS THAT EMPOWER PATIENTS TO COMMUNICATE THEIR CHEMOTHERAPY-RELATED SYMPTOMS.

155
MYELOSUPPRESSION IN PATIENTS WITH NON-HODGKIN LYMPHOMA TREATED WITH IBRITUMOMAB TIUXETAN (ZEVALIN™) RADIOIMMUNO-THERAPY: STRATEGIES FOR NURSING MANAGEMENT.

156
NAIL CHANGES FOLLOWING INTRAVENOUS TAXOTERE^®.

157
NO ABSTRACT

158
SYMPTOMS EXPERIENCED BY MESOTHELIOMA PATIENTS: USE OF THE LUNG CANCER SYMPTOM SCALE TO ASSESS IMPACT ON QUALITY OF LIFE IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA

159
NURSING ROLE IN THE DELIVERY OF IBRITUMOMAB TIUXETAN (ZEVALIN™) RADIOIMMUNOTHERAPY: WHAT TO EXPECT.

160
DOXIL^®-RELATED PALMAR-PLANTAR ERYTHRODYSESTHESIA: NURSING CHALLENGE AND OPPORTUNITY.

161
THALIDOMIDE: TOXICITY PROFILE AND NURSING IMPLICATIONS.

162
EVALUATION OF ADVANCED PRACTICE NURSING MANAGEMENT AND INTERVENTION IN A COLLABORATIVE ONCOLOGY AND PALLIATIVE CARE CLINICAL TRIAL FOR A LUNG CANCER PATIENT POPULATION IN A COMPREHENSIVE CANCER CENTER AT AN ACADEMIC INSTITUTION.

163
NURSING INTERVENTION PROTOCOL FOR PATIENTS WITH TERMINAL CANCER IN KOREA.

164
IMPROVING ONCOLOGY NURSES’ ATTITUDES AND KNOWLEDGE OF PALLIATIVE CARE.

165
UNDERGRADUATE NURSING EDUCATION IN END-OF-LIFE CARE: PARTICIPATION IN A PALLIATIVE CARE COMPANION PROGRAM.

166
HOPES, CONCERNS, AND EXPECTATIONS OF POOR PEOPLE LIVING WITH CANCER ABOUT CARE AT THE END OF LIFE.

167
ETHICS AT THE END OF LIFE: AUTONOMY AND CONTROL.

168
PROVIDING PALLIATIVE CARE TO THE UNDERSERVED: A CASE STUDY.

169
RETAINING NEW ONCOLOGY NURSES: A CHALLENGE FOR NURSING EDUCATION.

170
AN INNOVATIVE STRATEGY FOR REGISTERED NURSE RETENTION: A SELF-CONTAINED UNIT WITH AN AVAILABILITY SYSTEM.

171
KEEPING YOUR BEST: STAFF RETENTION.

171
UTILIZING A RECOGNITION DINNER TO ASSESS RETENTION OF ONCOLOGY NURSES.

173
A NOVEL CARE DELIVERY MODEL: UTILIZING A FLEXIBLE WORKWEEK TO IMPROVE NURSE RETENTION AND SATISFACTION.

174
FINDERS, KEEPERS: IMPROVING RECRUITMENT AND RETENTION: EFFORTS ON AN INPATIENT BLOOD AND MARROW TRANSPLANT UNIT.

175
SINK OR SWIM! RESCUE EFFORTS FOCUSED ON IMPROVING TEAMWORK, MORALE, AND CUSTOMER SERVICE THROUGH ADOPTING AN IMAGE OF NURSING SERIES.

176
GLUE: A STRATEGY TO IMPROVE NURSE RETENTION.

177
ONCOLOGY STAFF NURSES TAKE CONTROL OF THEIR PSYCHOSOCIAL WELLNESS: THE “CIRCLE OF CARE” PROGRAM.

178
CULTURAL COMPETENCE: ARE YOU PREPARED FOR THE CHALLENGE?

179
ONCOLOGY NURSING ASSISTANT DEVELOPMENT PROGRAM: A PARTNERSHIP APPROACH TO ADDRESS HEALTHCARE CHALLENGES.

180
SEXUALITY AND CANCER: HOW ONCOLOGY NURSES CAN ADDRESS IT BETTER.

181
A MODEL FOR PROFESSIONAL DEVELOPMENT.

182
PUBLISH OR PERISH: NURSES WRITING FOR THE PROFESSION.

183
COULD THIS BE LEPTOMENINGEAL METASTASIS?

184
LEVEL OF KNOWLEDGE AND COMPLIANCE WITH WORK PRACTICE GUIDELINES FOR PERSONNEL DEALING WITH CYTOTOXIC DRUGS: COMPARISON BY CLINICAL NURSE’S JOB CAREER AND WORK SITES.

185
EMPOWERING PATIENTS: ADVANCES IN TECHNOLOGY PROVIDE INNOVATIVE APPROACH TO MANAGING MALIGNANT PLEURAL EFFUSION.

186
POSITRON EMISSION TOMOGRAPHY: A NEW TREND IN ONCOLOGIC IMAGING.

187
DESPERATELY SEEKING SUSAN OR ANY OTHER ONCOLOGY NURSE TO BECOME OCN^® CERTIFIED (A.K.A. GOT OCN^®?).

188
SYNTHESIS OF RESEARCH EVIDENCE: COLLABORATION AMONG PRACTITIONERS, EDUCATORS, AND RESEARCHERS.

189
A COMPETENCY-BASED ORIENTATION FOR ADVANCED PRACTICE NURSES.

190
USE OF VACUUM-ASSISTED WOUND CLOSURE SYSTEM IN AN ONCOLOGY SETTING.

191
HYPOVITAMINOSIS D: IMPLICATIONS FOR ONCOLOGY PATIENTS RECEIVING BISPHOSPHONATE THERAPY.

192
IMPLEMENTATION OF A POCKET REFERENCE TOOL FOR REGISTERED NURSES INEXPERIENCED IN THE CARE OF COMPLEX ONCOLOGY PATIENTS IN THE HOSPITAL SETTING.

193
PREPARING NURSES IN BIOMEDICAL RESEARCH.

194
THE MASSACHUSETTS GENERAL HOSPITAL CANCER NURSING FELLOWSHIP: INTRODUCING CANCER CARE TO THE NEXT GENERATION OF NURSES.

195
ARE YOU READY TO PRACTICE?

196
“RESEARCH TO PRACTICE”: A PRACTICAL PROGRAM TO ENHANCE THE USE OF EVIDENCE-BASED PRACTICE AT THE UNIT LEVEL.

197
THE DEVELOPMENT OF SKILL SETS, COMPETENCIES, AND EDUCATIONAL PROGRAMMING TO PROMOTE GOOD CLINICAL PRACTICE FOR RESEARCH NURSES IN CLINICAL TRIALS.

198
INTEGRATION OF THE PEDIATRIC PATIENT POPULATION INTO A PREDOMINANTLY ADULT BLOOD AND MARROW TRANSPLANT PROGRAM.

199
IDENTIFYING SYMPTOMS THAT CLUSTER IN WOMEN WITH OVARIAN CANCER.

200
PERCEPTIONS OF THE CAREGIVING EXPERIENCE AND QUALITY OF LIFE OF MEXICAN/MEXICAN AMERICAN CAREGIVERS PROVIDING CARE TO ADULTS WITH ADVANCED CANCER.

201
DEPRESSIVE SYMPTOMS IN A SAMPLE OF WOMEN PARTICIPATING IN AN OVARIAN CANCER EARLY DETECTION PROGRAM.

202
CAUSAL ATTRIBUTIONS OF WOMEN WITH OVARIAN CANCER.

203
FACTORS THAT INFLUENCE QUALITY OF LIFE, HOPE, AND SYMPTOM DISTRESS IN BREAST AND COLORECTAL CANCER PATIENTS.

204
WHAT IT TAKES TO MAKE COOPERATIVE CARE WORK.

205
INCREASING TESTICULAR SELF-EXAMINATION IN ACTIVE DUTY SOLDIERS: AN INTERVENTION STUDY.

206
PSYCHOMETRIC PROPERTIES OF THE ITALIAN VERSION OF THE BRIEF FATIGUE INVENTORY.

207
THE DERMATOLOGY LIFE QUALITY INDEX: A USEFUL MEASURE FOR INDIVIDUALS WITH RADIATION SKIN REACTIONS IN SCOTTISH CANCER CENTRES.

208
MINI MENTAL STATUS EXAMINATION SCORES AS ELIGIBILITY CRITERIA FOR PATIENTS WITH PRIMARY BRAIN TUMORS ENTERING CLINICAL TRIALS.

209
COMPREHENSIVE SCREENING AND MANAGEMENT OF DISTRESS.

210
THE CHALLENGE OF DEFINING THE COMPLEX ROLE OF THE CLINICAL RESEARCH NURSE.

211
A CROSS-CULTURAL SURVEY (ONCOLOGY NURSING SOCIETY, EUROPEAN ONCOLOGY NURSING SOCIETY, AND MULTINATIONAL ASSOCIATION OF SUPPORTIVE CARE IN CANCER): PERCEPTION OF WORKLOAD, TIME CONSTRAINTS, AND IMPLICATIONS FOR OPTIMIZING ANTIEMETIC TREATMENT.

212
PILOT TEST OF A SLEEP INTERVENTION FOR CAREGIVERS OF PEOPLE WITH CANCER.

213
NONRESPONSE BIAS: AN ANALYSIS OF DATA FROM A STUDY OF THE ECONOMIC CONSEQUENCES OF CANCER SURVIVORSHIP.

214
INFORMATIONAL NEEDS OF KOREAN PATIENTS RECEIVING CHEMOTHERAPY.

215
THE LONGITUDINAL EFFECTS OF CANCER TREATMENT ON SEXUALITY IN INDIVIDUALS WITH LUNG CANCER.

216
STABILITY AND VALIDITY OF THE PRIORITIES INDEX.

217
APPLIED RESEARCH TRAINING SEMINAR: A MENTORING PROGRAM FOR NURSES.

218
DEVELOPING A PROFESSIONAL ABSTRACT: A TEAM APPROACH.

219
NEW NURSING STRATEGY TO IMPROVE PATIENT UNDERSTANDING OF INFORMED CONSENT FOR PHASE I CLINICAL TRIALS.

220
RESPONSE TO ANTIOXIDANT SUPPLEMENTS DURING RADIOTHERAPY.

221
THE DEVELOPMENT AND TESTING OF THE ROLE-RELATED MEANING SCALE FOR STAFF IN PEDIATRIC ONCOLOGY.

222
PEDIATRIC END-OF-LIFE NURSING EDUCATION.

223
LEADING WITH COMPASSION: THE EXPERIENCE OF STUDENTS AND TEACHERS CARING FOR ONCOLOGY PATIENTS.

224
AFRICAN AMERICAN WOMEN COPING WITH BREAST CANCER: A QUALITATIVE ANALYSIS.

225
IMPACT OF AN INPATIENT ONCOLOGY NURSE PRACTITIONER ON SELECTED OUTCOMES IN AN ACADEMIC MEDICAL CENTER.

226
RE-EVALUATING A PATIENT SAFETY PROGRAM IN AN ONCOLOGY NURSING SETTING.

227
THE BUCK STOPS HERE: ONLINE ACTUAL AND NEAR-MISS MEDICATION ERROR REPORTING.

228
ADDRESSING THE “MISSING PIECES” IN ACUTE MYELOID LEUKEMIA INDUCTION THERAPY.

229
PERFORMANCE IMPROVEMENT: EVALUATING AN EDUCATIONAL TOOL TO ENHANCE PATIENT OUTCOMES.

230
COMMITMENT TO QUALITY PATIENT CARE.

231
FACT ACCREDITATION: A MULTIDISCIPLINARY MODEL FOR PREPARATION FOR THE ACCREDITATION PROCESS.

232
GETTING TO THE ROOT OF CHEMOTHERAPY ERRORS: USING A ROOT CAUSE ANALYSIS APPROACH TO CHEMOTHERAPEUTIC MEDICATION ORDERING.

233
THE COMPREHENSIVE CANCER CENTER CONSORTIUM FOR QUALITY IMPROVEMENT’S PATIENT SATISFACTION INITIATIVE.

234
INCORPORATING KEY VALUES AND JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS FUNCTIONS INTO ONCOLOGY QUALITY IMPROVEMENT.

235
EVALUATION OF THE ROLE OF QUALITY IMPROVEMENT IN PROFESSIONAL DEVELOPMENT.

236
COLLABORATIVE APPROACH TO CASE MANAGEMENT.

237
THE DEVELOPMENT OF A VIRTUAL WORK GROUP OF THE ONCOLOGY NURSING SCOIETY CLINICAL TRIALS NURSES SPECIAL INTEREST GROUP: KEYS TO PRODUCTIVITY.

238
USING TECHNOLOGY TO IMPROVE CLINICAL PRACTICE.

239
COLORADO CANCER RESOURCE GUIDE ONLINE PROJECT.

240
USING PLAIN LANGUAGE AND INFORMATION MAPPING TO COMMUNICATE HEALTH INFORMATION ONLINE.

241
BAR CODE READER INTRODUCED AT GEORGETOWN UNIVERSITY HOSPITAL.

242
DEFINING THE CHARACTERISTICS OF YOUR PATIENT CARE AREA: USING TECHNOLOGY TO CREATE A UNIT PROFILE AND TO SIMPLIFY DATA COLLECTION AND ANALYSIS.

243
DEVELOPMENT OF A COMPUTERIZED ONCOLOGY NURSING DOCUMENTA-TION PATHWAY: COLLABORATION YIELDS RESULTS.